Clinical utility of remote monitoring for patients with cardiac implantable electrical devices

Yang, Shu; Stabenau, Hans F.; Kiernan, Katherine; Diamond, Jamie; Kramer, Daniel J.

doi:10.1007/s10840-022-01406-7

Cited by 2 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Designation of RM adherence as a quality-of-care metric, as the VHA has done through quarterly reports to VHA leadership and a real-time online dashboard viewable by leadership, could also help to increase RM adherence. Novel reimbursement models, such as a bundled annual rate for care of CIED patients, 16 , 25 , 26 could help secure adequate staffing so that clinicians can dedicate effort to these tasks.…”

Section: Discussionmentioning

confidence: 99%

Strategies to enhance remote monitoring adherence among patients with cardiovascular implantable electronic devices

Rotering,

Hysong,

Williams

et al. 2023

Heart Rhythm O2

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Strategies to enhance remote monitoring adherence among patients with cardiovascular implantable electronic devices

Rotering,

Hysong,

Williams

et al. 2023

Heart Rhythm O2

View full text Add to dashboard Cite

“…The increase in CIED implantations in the past decade has led to a greater need for patient follow-up [6]. In-office follow-ups are required every 3-12 months, but telemonitoring can extend the time between visits by securely transmitting diagnostic data from CIED to the manufacturer's server [7][8][9]. Telemonitoring assists in tracking the three main parameter groups of CIEDs treatment:…”

Section: Introductionmentioning

confidence: 99%

Remote Management of Patients with Cardiac Implantable Electronic Devices during the COVID-19 Pandemic

Nagy,

Pál-Jakab,

Kiss

et al. 2023

JCDD

View full text Add to dashboard Cite

Remote monitoring (RM) is the newest function of cardiac implantable electronic devices (CIEDs). In our observational retrospective analysis, we aimed to assess whether telecardiology could be a safe alternative to routine outpatient examinations during the COVID-19 pandemic. The in- and outpatient visits, the number of acute cardiac decompensation episodes, the RM data from CIEDs, and general condition were examined via questionnaires (KCCQ, EQ-5D-5L). Regarding the enrolled 85 patients, the number of personal patient appearances was significantly lower in the year following the pandemic outbreak compared to the previous year (1.4 ± 1.4 and 1.9 ± 1.2, p = 0.0077). The number of acute decompensation events was five before and seven during lockdown (p = 0.6). Based on the RM data, there was no significant difference in heart failure (HF) markers (all related p > 0.05); only patient activity increased after restrictions were lifted compared to that before the lockdown (p = 0.03). During restrictions, patients reported increased anxiety and depression compared to their previous state (p < 0.001). There was no subjective change in the perception of HF symptoms (p = 0.7). Based on the subjective perception and CIED data, the quality of life of patients with CIED did not deteriorate during the pandemic, but their anxiety and depression intensified. Telecardiology may be a safe alternative to routine inpatient examination.

show abstract

Clinical utility of remote monitoring for patients with cardiac implantable electrical devices

Cited by 2 publications

References 16 publications

Strategies to enhance remote monitoring adherence among patients with cardiovascular implantable electronic devices

Strategies to enhance remote monitoring adherence among patients with cardiovascular implantable electronic devices

Remote Management of Patients with Cardiac Implantable Electronic Devices during the COVID-19 Pandemic

Contact Info

Product

Resources

About